| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |